Skip to main content
Global
Regions
WHO Regional websites
Africa
Americas
South-East Asia
Europe
Eastern Mediterranean
Western Pacific
Countries
Countries, territories and areas in the WHO Western Pacific Region:
American Samoa (USA)
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia (France)
Guam (USA)
Hong Kong SAR (China)
Indonesia
Japan
Kiribati
Lao People's Democratic Republic
Macao SAR (China)
Malaysia
Marshall Islands
Micronesia, Federated States of
Mongolia
Nauru
New Caledonia (France)
New Zealand
Niue
Northern Mariana Islands (USA)
Palau
Papua New Guinea
Philippines
Pitcairn Islands (UK)
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna (France)
When autocomplete results are available use up and down arrows to review and enter to select.
Western Pacific
Japan
Home
Health Topics
Our work
News
Emergencies
About us
Home
/
News
/
Detail Global
/
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
1 December 2025
News release
Media Contacts
WHO Media Team
World Health Organization
Email:
mediainquiries@who.int
Related
WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults
JAMA article: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
Questions and answers on GLP-1 therapies
WHO's work on obesity
